Ds5
Peptide therapy: benefits, side effects, cost and protocols
C29H32F6O5
DS5 is an investigational peptide being studied for its potential therapeutic applications. Research is ongoing to characterize its mechanism of action and clinical utility.
Sources: FDA / PubMed / ClinicalTrials.gov View
Spec sheet
- FDA status
- Research Only Not currently approved for human use in the US. Available as a research compound. Not eligible for compounding.
- Evidence
- Moderate Evidence
Who it's for
Who Ds5 is usually considered for
- Research applications
- 3 preclinical studies
- Limited human trials or strong preclinical
Mechanism
How Ds5 works
Mechanisms under investigation.
Evidence
Key studies
92 papers on PubMed / 37 human trials
- 01
Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results
- 02
Martelli M, Ceriani L, Ciccone G et al
J Clin Oncol / RCT
Omitting radiotherapy in PMBCL with complete metabolic response achieved non-inferior 30-month PFS (96.2% vs 98.5%).
- 03
Omitting radiotherapy in PMBCL with complete metabolic response achieved non-inferior 30-month PFS (96.2% vs 98.5%)
- 04
Is Telenursing an Effective Method to Control BMI and HbA1c in Illiterate Patients Aged 50 Years and Older With Type 2 Diabetes? A Randomized Controlled Clinical Trial
J Caring Sci / RCT
Telenursing reduces HbA1c and BMI in older illiterate type 2 diabetes patients.
- 05
Telenursing reduces HbA1c and BMI in older illiterate type 2 diabetes patients
- 06
Optimal timing and criteria of interim PET in DLBCL: a comparative study of 1692 patients
- 07
Eertink JJ, Burggraaff CN, Heymans MW et al
Blood Adv / Blood Adv
- 08
Interim-PET after 2 or 4 R-CHOP cycles predicts DLBCL prognosis; optimal criteria depend on clinical context
- 09
Caries lesions progression in adults: A prospective 2-year cohort study
- 10
Abdalla H, Allison PJ, Madathil SA et al
Community Dent Oral Epidemiol / Community Dent Oral Epidemiol
Active caries lesions progress at higher rates than inactive lesions; severity and location predict progression.
Compound
Ds5 compound data
- Formula
- C29H32F6O5
- Mol. weight
- 574.6 g/mol
- PubChem CID
- 57432986 ↗
- IUPAC
- (4S)-5-[4-[1-ethyl-1-[3-methyl-4-[4,4,4-trifluoro-3-hydroxy-3-(trifluoromethyl)but-1-ynyl]phenyl]propyl]-2-methyl-phenoxy]-4-hydroxy-pentanoic acid
FAQ
Ds5 questions
What is DS5?
DS5 is an emerging research peptide with limited publicly available data. Research applications are still being explored.
How does DS5 work?
Mechanisms under investigation.
Is DS5 legal to buy?
DS5 is sold as a research chemical for laboratory use only. It is not approved for human use by the FDA. Regulations vary by jurisdiction.
Where can I buy DS5?
DS5 is available as a research compound from verified online vendors. Always verify third-party testing before purchasing.
What category does DS5 belong to?
DS5 is primarily classified as a other & emerging peptide. Miscellaneous and emerging peptides with unique or developing research profiles.
What are the research benefits of DS5?
DS5 has been studied for: Research applications. Limited data; emerging research compound.
Considering Ds5?
The 2-minute quiz matches you with licensed providers who offer it. A clinician decides if it fits.